China Electronic System Engineering No. 2 Construction Co., LTD. (hereinafter referred to as "CLP No. 2 "),founded in 1953, belongs to the world's top 500 - China Electronic Information Industry Group Co., LTD. (CEC), is the earliest engaged in clean engineering, industrial construction engineering large-scale central enterprises. The company closely follows the national strategy, to create a pharmaceutical industry 4.0 intelligent manufacturing platform for customers, to provide from design consulting, engineering construction, debugging detection to intelligent operation and maintenance and other engineering life cycle integration services, with advanced construction technology and product services to continue to promote the progress of industrial environment industry.
As a leader in the integration of pharmaceutical engineering construction in China, the company has rich engineering design and construction experi- ence in the pharmaceutical sectors such as biological medicine, chemical medicine, and proprietary Chinese medicine. It has successively undertaken engineering projects of well-known pharmaceutical enterprises such as SmithKline, Bayer, Astrazeneca, Novo Nordisk, Novartis, Yangzijiang Pharma- ceutical, and Qilu Pharmaceutical, and has a number of industry-leading construction technologies. For many years, it has been rated as "AAA" credit rating and high-tech enterprises by national professional rating agencies. In the future, the company will continue to uphold the core values of "integ- rity, responsibility, innovation, forging ahead", adhere to the brand concept of "beginning to end, lean construction", continue to innovate technology and services, create higher value for customers, and contribute to the development of national high-tech industry!

more >
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights: